160 related articles for article (PubMed ID: 8480584)
1. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.
Sakuma H; Takeda K; Tagami T; Nakagawa T; Okamoto S; Konishi T; Nakano T
Am Heart J; 1993 May; 125(5 Pt 1):1323-8. PubMed ID: 8480584
[TBL] [Abstract][Full Text] [Related]
2. Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.
Sieverding L; Jung WI; Breuer J; Widmaier S; Staubert A; van Erckelens F; Schmidt O; Bunse M; Hoess T; Lutz O; Dietze GJ; Apitz J
Am J Cardiol; 1997 Aug; 80(3A):34A-40A. PubMed ID: 9293954
[TBL] [Abstract][Full Text] [Related]
3. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
[TBL] [Abstract][Full Text] [Related]
4. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-diethylenetriaminepenta-acetic acid enhanced magnetic resonance imaging in hypertrophic cardiomyopathy].
Koito H; Suzuki J; Nakamori H; Ohkubo N; Wakayama Y; Iwasaka T; Inada M; Katoh T
J Cardiol; 1995 Apr; 25(4):163-70. PubMed ID: 7752050
[TBL] [Abstract][Full Text] [Related]
6. Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.
Jung WI; Sieverding L; Breuer J; Schmidt O; Widmaier S; Bunse M; van Erckelens F; Apitz J; Dietze GJ; Lutz O
J Magn Reson; 1998 Jul; 133(1):232-5. PubMed ID: 9654494
[TBL] [Abstract][Full Text] [Related]
7. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
[TBL] [Abstract][Full Text] [Related]
8. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy.
de Roos A; Doornbos J; Luyten PR; Oosterwaal LJ; van der Wall EE; den Hollander JA
J Magn Reson Imaging; 1992; 2(6):711-9. PubMed ID: 1446116
[TBL] [Abstract][Full Text] [Related]
9. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
[TBL] [Abstract][Full Text] [Related]
10. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
[TBL] [Abstract][Full Text] [Related]
11. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise.
Yabe T; Mitsunami K; Okada M; Morikawa S; Inubushi T; Kinoshita M
Circulation; 1994 Apr; 89(4):1709-16. PubMed ID: 8149536
[TBL] [Abstract][Full Text] [Related]
12. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
[TBL] [Abstract][Full Text] [Related]
13. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
[TBL] [Abstract][Full Text] [Related]
15. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS.
Okada M; Mitsunami K; Inubushi T; Kinoshita M
Magn Reson Med; 1998 May; 39(5):772-82. PubMed ID: 9581609
[TBL] [Abstract][Full Text] [Related]
16. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
[TBL] [Abstract][Full Text] [Related]
17. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.
Yabe T; Mitsunami K; Inubushi T; Kinoshita M
Circulation; 1995 Jul; 92(1):15-23. PubMed ID: 7788910
[TBL] [Abstract][Full Text] [Related]
18. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
[TBL] [Abstract][Full Text] [Related]
19. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.
Jung WI; Sieverding L; Breuer J; Hoess T; Widmaier S; Schmidt O; Bunse M; van Erckelens F; Apitz J; Lutz O; Dietze GJ
Circulation; 1998 Jun; 97(25):2536-42. PubMed ID: 9657474
[TBL] [Abstract][Full Text] [Related]
20. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
